Time course of discordant BMIPP and thallium uptake after ischemia and reperfusion in a rat model

Journal of Nuclear Medicine

Volumn 46, Issue 1, 2005, Pages 172-175

  Higuchi, Takahiro ^a,b   Taki, Junichi ^b   Nakajima, Kenichi ^b   Kinuya, Seigo ^b   Namura, Masanobu ^a   Tonami, Norihisa ^b  

^a KANAZAWA CARDIOVASCULAR HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Autoradiography; BMIPP; Fatty acid metabolism; Ischemia; Reperfusion

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 125; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CONVALESCENCE; DRUG UPTAKE; FATTY ACID METABOLISM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; EVALUATION; HEART; HEART MUSCLE; METABOLIC CLEARANCE RATE; METABOLISM; REPERFUSION INJURY; SCINTISCANNING; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY ACIDS; HEART; IODINE RADIOISOTOPES; IODOBENZENES; MALE; METABOLIC CLEARANCE RATE; MYOCARDIUM; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; REPERFUSION INJURY; THALLIUM; TISSUE DISTRIBUTION;

EID: 15044339224     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med. 1991;32:565-578.
2. Schwaiger M, Schelbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol. 1985;6:336-347.
3. Schelbert HR, Henze E, Keen R, et al. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs. Am Heart J. 1983;106:736-750.
4. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis. 1981;23:321-336.
5. Taki J, Nakajima K, Matsunari I, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med. 1997;38:1503-1510.
6. Matsunari I, Saga T, Taki J, et al. Improved myocardial fatty acid utilization after percutaneous transluminal coronary angioplasty. J Nucl Med. 1995;36:1605-1607.
7. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med. 1996;37:718-722.
8. Franken PR, Hambye AS, De Geeter FW. BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction. Int J Card Imaging. 1999;15:27-34.
9. Knapp FF Jr, Kropp J. BMIPP: design and development. Int J Card Imaging. 1999;15:1-9.
10. Nohara R, Hosokawa R, Hirai T, et al. Basic kinetics of l5-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium. Int J Card Imaging. 1999;15:11-20.
11. Nohara R. Lipid metabolism in the heart: contribution of BMIPP to the diseased heart. Ann Nucl Med. 2001;15:403-409.
12. Taki J, Matsunari I, Nakajima K, Tonami N. BMIPP compared with thallium redistribution. Int J Card Imaging. 1999;15:49-59.
13. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med. 1994;35:1279-1285.
14. Taki J, Nakajima K, Matsunari I, Bunko H, Takada S, Tonami N. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid. Eur J Nucl Med. 1995;22:1385-1392.
15. Nakajima K, Shimizu K, Taki J, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med. 1995;36:1934-1940.
16. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J. Nucl Med. 1996;37:757-761.
17. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med. 1995;36:1043-1050.
18. Noriyasu K, Mabuchi M, Kuge Y, et al. Serial changes in BMIPP uptake in relation to thallium uptake in the rat myocardium after ischaemia. Eur J Nucl Med Mol Imaging. 2003;30:1644-1650.
19. 123I-beta-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med. 1989;15:341-345.
20. Nohara R, Okuda K, Ogino M, et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med. 1996;37:1403-1407.
21. 201Tl dual-isotope SPECT. Ann Nucl Med. 2002;16: 563-568.
22. Hashimoto A, Nakata T. Tsuchihashi K, Tanaka S, Fujimori K, Iimura O. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol. 1996;77:25-30.
23. Misumi I. Kimura Y, Hokamura Y, Yamabe H, Ueno K. Myocardial rest iodine-123-beta-methyl-iodophenyl-pentadecanoic acid scintigraphy compared with dipyridamole stress thallium-201 scintigraphy in unstable angina. Intern Med. 1998;37:21-26.
24. Fukuzawa S, Inagaki M, Morooka S, Inoue T. Sugioka J, Ozawa S. An effective tool to detect lesions causing unstable angina with multivessel disease: iodine-123-betamethyl-p-iodophenyl-pentadecanoic acid single photon emission computed tomography. J Cardiol. 1996;28:191-198.
25. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S- methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med. 1992;19:775-782.
26. Kurata C, Tawarahara K, Taguchi T, et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med. 1992;33:6-13.
27. Sloof GW, Visser FC, Bax JJ, et al. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med. 1998;39:255-260.